- Home
- RPRX vs HST Comparison
RPRX vs HST Comparison
Compare RPRX & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- HST
- Stock Information
- Founded
- RPRX 1996
- HST 1927
- Country
- RPRX United States
- HST United States
- Employees
- RPRX N/A
- HST N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- HST Real Estate Investment Trusts
- Sector
- RPRX Health Care
- HST Real Estate
- Exchange
- RPRX Nasdaq
- HST Nasdaq
- Market Cap
- RPRX 14.2B
- HST 11.9B
- IPO Year
- RPRX 2020
- HST N/A
- Fundamental
- Price
- RPRX $31.13
- HST $14.21
- Analyst Decision
- RPRX Strong Buy
- HST Buy
- Analyst Count
- RPRX 5
- HST 14
- Target Price
- RPRX $41.60
- HST $19.54
- AVG Volume (30 Days)
- RPRX 4.3M
- HST 9.7M
- Earning Date
- RPRX 05-08-2025
- HST 04-30-2025
- Dividend Yield
- RPRX 2.83%
- HST 6.33%
- EPS Growth
- RPRX N/A
- HST N/A
- EPS
- RPRX 1.91
- HST 0.99
- Revenue
- RPRX $2,263,576,000.00
- HST $5,691,000,000.00
- Revenue This Year
- RPRX $33.46
- HST $4.76
- Revenue Next Year
- RPRX $4.44
- HST $3.02
- P/E Ratio
- RPRX $16.28
- HST $14.35
- Revenue Growth
- RPRX N/A
- HST 7.03
- 52 Week Low
- RPRX $24.05
- HST $13.83
- 52 Week High
- RPRX $34.20
- HST $20.85
- Technical
- Relative Strength Index (RSI)
- RPRX 33.61
- HST 32.00
- Support Level
- RPRX $32.26
- HST $14.25
- Resistance Level
- RPRX $34.14
- HST $15.14
- Average True Range (ATR)
- RPRX 0.76
- HST 0.40
- MACD
- RPRX -0.33
- HST -0.04
- Stochastic Oscillator
- RPRX 14.00
- HST 23.46
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.